Driving Innovation and Extending Its Global Reach
Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."
Topics
Why CDMOs Should Consider Value-Based Pricing
Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.
The Importance of On-line Process Control
Modern therapies of different diseases very often utilize drugs derived from living cells. However, manufacturing of these biopharmaceutical products is a complex process.
Experts Statements: Gabriel Haering, Cerbios Pharma
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.
